Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Peloton Interactive, Inc. announced its Q4 and full fiscal year 2026 financial results, highlighting its first full year of GAAP net profitability with net income of $63 million and an Adjusted EBITDA of $468 million, a 16% year-over-year increase. Total revenue reached $2.446 billion, slightly above guidance, driven by strong equipment sales. The …
Cartesian Therapeutics reported Q2 2026 financial results and business updates highlighting progress in its CAR-T cell therapy pipeline targeting autoimmune diseases including myasthenia gravis, myositis, and juvenile dermatomyositis. The company secured a strategic licensing agreement with WestGene to develop an in vivo CAR-T platform, expects mul…
Immunovant, a clinical-stage immunology company, announced its financial results for the quarter ended June 30, 2026, highlighting a cash position sufficient to support the potential launch of IMVT-1402 in Graves’ disease. The company reported increased R&D expenses reflecting advancement in clinical trials across six indications including Graves’ …
Korro Bio announced its Q2 2026 financial results, highlighting progress in its OPERA platform technology with the upcoming first-in-human trial for KRRO-121 in hyperammonemia and orphan drug designation from the EMA. The company also nominated KRRO-111 as a development candidate for Alpha-1 Antitrypsin Deficiency (AATD), demonstrating significant …
Immunocore Holdings plc reported robust second quarter 2026 financial results, highlighted by 18% year-over-year growth in net revenues for KIMMTRAK reaching $115.9 million. The company is advancing multiple Phase 3 clinical trials, including the TEBE-AM trial for advanced cutaneous melanoma and the PRISM-MEL-301 trial for first-line melanoma, with…
Roivant Sciences reported Q1 FY2027 financial results and provided an update on key pipeline developments. The company is preparing for the commercial launch of brepocitinib for dermatomyositis by September 2026 and expects topline data later this year for several late-stage trials including non-infectious uveitis, cutaneous sarcoidosis, and pulmon…
Priovant Therapeutics has commenced patient enrollment in the global Phase 3 BEACON+ trial evaluating brepocitinib for cutaneous sarcoidosis (CS), following positive Phase 2 results and FDA Breakthrough Therapy Designation. The drug is also progressing in multiple orphan disease indications including dermatomyositis, non-infectious uveitis, and lic…
Aya Gold & Silver Inc. announced the acquisition of a significant exploration portfolio in Morocco, adding 259 km² of land across three projects (Zagora, Agadir-Melloul, and Goulmim). This acquisition increases their total land holdings by 35.4%, strengthens their district-scale exploration strategy, and enhances exposure to precious, base, and cri…
Radian's recent quarter disappointed as newly acquired P&C and specialty lines pressured results, but the balance sheet remains healthy, the stock trades below 10x earnings, and the company's strategic pivot (including the $1.7B Inigo deal) points to upside. This is a tactical long for the mid term (45 trading days) with defined entry, stop and tar…
Shares of major data-storage companies plunged in premarket trading after Sandisk and Western Digital issued quarterly revenue forecasts that topped consensus but disappointed investors holding ambitious AI-era expectations. The declines highlight how quickly market enthusiasm can turn when even robust results fall short of heightened forecasts.
Aclaris Therapeutics released its Q2 2026 financial results, showing increased net loss due to expanded R&D investing in pipeline candidates. The company reaffirmed timelines for pivotal clinical data readouts from multiple Phase 1b and Phase 2 trials targeting immuno-inflammatory diseases such as asthma, atopic dermatitis, and lichen planus. It al…
FIFA’s recent efforts to close ranks around President Gianni Infantino after a contentious proposal to sell part of the World Cup’s commercial future have calmed public acrimony but are unlikely to end scrutiny of the organisation’s governance. FIFA apologised to its 211 member associations for the way the plan was handled, pledged a process review…
Sterling eased slightly while the euro slipped, with both currencies trading cautiously ahead of Friday's U.S. non-farm payrolls report. The dollar remained relatively steady after hawkish comments from Federal Reserve officials, even as an Iran-Oman shipping deal and a drop in Brent crude to below $80 a barrel reduced near-term inflation concerns.
L’Oreal shares climbed after Jefferies raised its recommendation and price target, a move reinforced by the company's record first-half 2026 revenue, robust like-for-like sales growth and a best-ever operating margin. E-commerce expansion and broad division-level growth underpinned investor confidence, while a constructive European macro environmen…
Equity research firm Summit Insights downgraded Western Digital to Hold, pointing to execution and margin risks tied to the company’s move to heat-assisted magnetic recording (HAMR). Analyst Kinngai Chan expects higher costs during the HAMR transition, a forecasted decline in average selling price per exabyte when HAMR drives begin shipping in 2027…
Pharvaris announced the publication of a landmark qualitative study assessing the burden of acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), highlighting significant patient challenges including frequent misdiagnoses and multifaceted impacts on quality of life. The study validated patient-reported outcome measures which are now infor…
TransUnion's Q2 2026 Credit Industry Insights Report reveals that consumer credit access in the U.S. continues to expand steadily with total outstanding balances reaching $18.6 trillion. Lenders are managing risk through strategies like smaller credit lines, resulting in stable delinquency rates despite moderate increases in debt usage. Growth in c…
SoftBank Group shares dropped sharply after the company released Q1 FY2026 results that combined strong near-term profits with a weaker forward-looking picture. Net income outperformed expectations and investment gains surged, but a sizable fall in pro forma net asset value and disclosure of a $10 billion margin loan tied to its OpenAI holding rais…
TD Cowen reports the Consumer Financial Protection Bureau has forwarded a Section 1033 open banking proposal to the Office of Management and Budget for review, and expects a new rule to be published in late August or early September. The firm anticipates the proposal will permit some fee-free consumer-initiated data transfers while providing banks …
DNOW Inc. announced its second quarter 2026 financial results, reporting $1.3 billion in revenue with a 13% sequential increase in the U.S. segment and a record $133 million in cash flow from operating activities. Adjusted EBITDA increased by 54% sequentially to $60 million. The company repurchased $25 million of its common stock in Q2 and $75 mill…
Bullish, a US-listed digital asset platform focused on institutional crypto trading and market infrastructure, released its unaudited monthly metrics for July 2026. These include detailed metrics on trading volumes, average trading spreads, and volatility for major cryptocurrencies BTC and ETH, derived from its proprietary CoinDesk data services. T…
Kinross Gold Corporation received a credit rating upgrade from S&P Global Ratings, improving its long-term issuer credit and unsecured debt ratings from 'BBB-' to 'BBB' with a stable outlook. The upgrade recognizes Kinross’s strengthened financial position driven by strong cash flow, debt reduction, and operational discipline, underpinned by a net …
Onity Group Inc. announced its Q2 2026 results showing record origination volumes and significant subservicing additions which drove double-digit revenue and servicing growth. However, the company reported a net loss of $13 million largely due to $9 million in costs from asset sales and servicing transfers, and $24 million in unfavorable asset fair…
Brilliant Earth Group, Inc. delivered solid second quarter results in 2026, with 6% year-over-year net sales growth, $5.8 million in adjusted EBITDA exceeding the upper end of guidance, and substantial bookings growth in fine jewelry. The company expanded its gross margin and improved operating expense leverage while opening a new flagship showroom…
Diageo's stock climbed sharply after the drinks group released fiscal 2026 preliminary results alongside a Capital Markets Day presentation that outlined CEO Sir Dave Lewis's turnaround plan. Though organic net sales fell, the company reported higher organic operating profit, expanded margins and unveiled a multi-year restructuring expected to deli…
